Erratum: MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer (Molecular Therapy - Oncolytics (2020) 16 (207–218), (S2372770520300085), (10.1016/j.omto.2020.01.002))

Huitao Liu, Yuan Chao Xue, Haoyu Deng, Yasir Mohamud, Chen Seng Ng, Axel Chu, Chinten James Lim, William W. Lockwood, William W.G. Jia, Honglin Luo

Research output: Contribution to journalComment / DebateResearchpeer-review

2 Citations (Scopus)

Abstract

(Mol. Ther. Oncolytics 16, 207–218; March 27, 2020) In the originally published version of this article, we made errors regarding the titer of coxsackievirus B3 during TCID50 calculation. The dose of virus used for the animal study was 1 × 106 PFU instead of 1 × 108 PFU, and, in Figures 5A and 5C, all the virus titers need to be divided by 100. The corrected Figure 5 is provided below. The authors regret this error. [Figure presented] [Figure presented]

Original languageEnglish
Pages (from-to)1-2
Number of pages2
JournalMolecular Therapy - Oncolytics
Volume20
DOIs
Publication statusPublished - 26 Mar 2021
Externally publishedYes

Cite this